Daily Trades
- Dylan Jovine
GLP-1 stimulates the production of incretin, a naturally occurring hormone
that makes us feel full.
- Dylan Jovine
I made a bet to hold shares and see how the market digested the stock.
- Dylan Jovine
That was the first thought I had when I saw that shares of Viking Therapeutics (SYM: VKTX) jumped 121% yesterday after posting great results for its weight-loss drug.
- Dylan Jovine
Lots of folks wrote in yesterday to ask about Krystal Biotech (SYM: KRYS).
- Dylan Jovine
I recommend selling half your shares of Viking Therapeutics (SYM: VKTX) here at $30.58, a 63% gain from our average recommended price of $18.71.
- Dylan Jovine
The 30% sell-off in biotech stocks has given us the opportunity to buy things for the best prices I’ve seen all year.
- Dylan Jovine
The Wall Street Journal calls this new drug “King Kong”…
- Dylan Jovine
The company has strong technology…made even stronger by the fact that NVIDIA invested $50 million in them this past July
- Dylan Jovine
Lot of folks have written in to ask whether I still think Eli Lilly (SYM: LLY) is a buy up here.
- Dylan Jovine
Let's start by closing out one of our older positions for a small profit.
deal of the month
Categories
New Housing Report Coming This Week! 👀 @MarketBeatMedia
Dylan Jovine | JP Morgan's CEO Says - "Conditions Are Treacherous and Getting Worse"
Commodity Price Drops: A Recession Warning? @MarketBeatMedia
Recent posts
Tags
Connect with Us
- Dylan Jovine
GLP-1 stimulates the production of incretin, a naturally occurring hormone
that makes us feel full.
- Dylan Jovine
I made a bet to hold shares and see how the market digested the stock.
- Dylan Jovine
That was the first thought I had when I saw that shares of Viking Therapeutics (SYM: VKTX) jumped 121% yesterday after posting great results for its weight-loss drug.
- Dylan Jovine
Lots of folks wrote in yesterday to ask about Krystal Biotech (SYM: KRYS).
- Dylan Jovine
I recommend selling half your shares of Viking Therapeutics (SYM: VKTX) here at $30.58, a 63% gain from our average recommended price of $18.71.
- Dylan Jovine
The 30% sell-off in biotech stocks has given us the opportunity to buy things for the best prices I’ve seen all year.
- Dylan Jovine
The Wall Street Journal calls this new drug “King Kong”…
- Dylan Jovine
The company has strong technology…made even stronger by the fact that NVIDIA invested $50 million in them this past July
- Dylan Jovine
Lot of folks have written in to ask whether I still think Eli Lilly (SYM: LLY) is a buy up here.
- Dylan Jovine
Let's start by closing out one of our older positions for a small profit.
Get FREE Daily Stock Tips
Join and receive market insider stock picks, trade alerts and unique investing insights
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.
